TENX: Tenax Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 25.19
Enterprise Value ($M) -73.13
Book Value ($M) 91.99
Book Value / Share 25.67
Price / Book 0.26
NCAV ($M) 91.99
NCAV / Share 24.29
Price / NCAV 0.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -1.25
Return on Equity (ROE) -1.80

Liquidity (mrq)
Quick Ratio 38.95
Current Ratio 38.95

Balance Sheet (mrq) ($M)
Current Assets 96.69
Assets 96.69
Liabilities 4.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -19.49
Net Income -17.60
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 99.87

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
9 days ago 13G/A S.H.N. Financial Investments Ltd. 4.99 67.34
02-14 13G/A Janus Henderson Group Plc 5.40 -46.32
01-15 13G/A Dellora Investments LP 10.30
11-14 13G Lind Global Fund II LP 9.90
11-14 13G/A CVI Investments, Inc. 0.00 -100.00
11-13 13G/A Stonepine Capital Management, LLC 9.99 0.00
11-12 13G Adage Capital Management, L.P. 9.99
09-10 13G Price T Rowe Associates Inc /md/ 19.99
08-19 13G Venrock Healthcare Capital Partners III, L.P. 9.99
08-19 13G Biotechnology Value Fund L P 9.99
08-14 13G Vivo Opportunity Fund Holdings, L.P. 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K rrrr UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C., 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C., 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-25 554 3,778 14.66
2025-03-24 6,425 51,122 12.57
2025-03-21 13,334 100,977 13.20

(click for more detail)

Similar Companies
SYBX – Synlogic, Inc. TCRT – Alaunos Therapeutics, Inc.
TELO – Telomir Pharmaceuticals, Inc. TGTX – TG Therapeutics, Inc.
THAR – Tharimmune, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Tenax Therapeutics